Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keke Gui
Denosumab Versus Zoledronic Acid for Preventing Symptomatic Skeletal Events in Asian Postmenopausal Women With Oestrogen-Receptor-Positive Advanced Breast Cancer: An Outcome Analyses With a Mean Follow-Up of 3 Years
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Related publications
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase 1b Study of Orteronel in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic Breast Cancer
Investigational New Drugs
Oncology
Pharmacology
Breast-Cancer Adjuvant Therapy With Zoledronic Acid
New England Journal of Medicine
Medicine
Incidence of Hypocalcemia in Patients With Post-Menopausal Osteoporosis or Cancer Skeletal Related Events After Denosumab in Comparison to Zoledronic Acid in a Community Hospital Setting
Journal of Pharmacovigilance
Oestrogen Receptor Status and Survival in Women With BRCA2-associated Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Denosumab and Breast Cancer Risk in Postmenopausal Women: A Population-Based Cohort Study
British Journal of Cancer
Cancer Research
Oncology
Oestrogen Plus Progestogen Increased Risk of Breast Cancer in Postmenopausal Women
Evidence-Based Medicine
Medicine
Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
